166 related articles for article (PubMed ID: 10498391)
1. Immunological methods for detection of carcinogen-DNA damage in humans.
Santella RM
Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):733-9. PubMed ID: 10498391
[TBL] [Abstract][Full Text] [Related]
2. Immunologic methods for the detection of carcinogen adducts in humans.
Santella RM; Yang XY; Hsieh LL; Young TL
Prog Clin Biol Res; 1990; 340C():247-57. PubMed ID: 2199982
[TBL] [Abstract][Full Text] [Related]
3. Quantification of methoxsalen-DNA adducts with specific antibodies.
Santella RM; Gasparro FP; Edelson RL
IARC Sci Publ; 1986; (78):127-39. PubMed ID: 3583386
[TBL] [Abstract][Full Text] [Related]
4. Human biomonitoring: state of the art.
Angerer J; Ewers U; Wilhelm M
Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
[TBL] [Abstract][Full Text] [Related]
5. Correlation between biomarkers of human exposure to genotoxins with focus on carcinogen-DNA adducts.
Gyorffy E; Anna L; Kovács K; Rudnai P; Schoket B
Mutagenesis; 2008 Jan; 23(1):1-18. PubMed ID: 17989146
[TBL] [Abstract][Full Text] [Related]
6. Exposure biomarkers for the study of toxicological impact on carcinogenic processes.
Farmer PB
IARC Sci Publ; 2004; (157):71-90. PubMed ID: 15055291
[TBL] [Abstract][Full Text] [Related]
7. Environmental and chemical carcinogenesis.
Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
[TBL] [Abstract][Full Text] [Related]
8. DNA adducts as markers of exposure and risk.
Phillips DH
Mutat Res; 2005 Sep; 577(1-2):284-92. PubMed ID: 15922369
[TBL] [Abstract][Full Text] [Related]
9. Immunological methods for detection of carcinogen-DNA adducts.
Adamkiewicz J; Nehls P; Rajewsky MF
IARC Sci Publ; 1984; (59):199-215. PubMed ID: 6085833
[TBL] [Abstract][Full Text] [Related]
10. Immunologic detection of benzo(a)pyrene-DNA adducts.
Santella RM; Zhang YJ
Methods Mol Biol; 2011; 682():271-8. PubMed ID: 21057934
[TBL] [Abstract][Full Text] [Related]
11. Genotoxicity of environmental agents assessed by the alkaline comet assay.
Møller P
Basic Clin Pharmacol Toxicol; 2005; 96 Suppl 1():1-42. PubMed ID: 15859009
[TBL] [Abstract][Full Text] [Related]
12. The uses of carcinogen-DNA adduct measurement in establishing mechanisms of mutagenesis and in chemoprevention.
Baird WM; Mahadevan B
Mutat Res; 2004 Mar; 547(1-2):1-4. PubMed ID: 15013693
[TBL] [Abstract][Full Text] [Related]
13. In situ detection of acetylaminofluorene-DNA adducts in human cells using monoclonal antibodies.
Iwamoto TA; Kobayashi N; Imoto K; Yamamoto A; Nakamura Y; Yamauchi Y; Okumura H; Tanaka A; Hanaoka F; Shibutani S; Miyagawa S; Mori T
DNA Repair (Amst); 2004 Nov; 3(11):1475-82. PubMed ID: 15380103
[TBL] [Abstract][Full Text] [Related]
14. Carcinogen-modified DNA and specific humoral immunity toward carcinogen-DNA adducts. A review.
Verdina A
Ann Ist Super Sanita; 2006; 42(2):189-94. PubMed ID: 17033140
[TBL] [Abstract][Full Text] [Related]
15. Applicability of induced sputum for molecular dosimetry of exposure to inhalatory carcinogens: 32P-postlabeling of lipophilic DNA adducts in smokers and nonsmokers.
Besaratinia A; Maas LM; Van Breda SG; Curfs DM; Kleinjans JC; Wouters EF; Van Schooten FJ
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):367-72. PubMed ID: 10794480
[TBL] [Abstract][Full Text] [Related]
16. Dna adducts, mutations, and cancer 2000.
Hemminki K; Koskinen M; Rajaniemi H; Zhao C
Regul Toxicol Pharmacol; 2000 Dec; 32(3):264-75. PubMed ID: 11162720
[TBL] [Abstract][Full Text] [Related]
17. Carcinogen-DNA and carcinogen-protein adducts in molecular epidemiology.
Wild CP; Pisani P
IARC Sci Publ; 1997; (142):143-58. PubMed ID: 9354917
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis.
Li D; Firozi PF; Wang LE; Bosken CH; Spitz MR; Hong WK; Wei Q
Cancer Res; 2001 Feb; 61(4):1445-50. PubMed ID: 11245449
[TBL] [Abstract][Full Text] [Related]
19. Lipid peroxidation-induced DNA damage in cancer-prone inflammatory diseases: a review of published adduct types and levels in humans.
Nair U; Bartsch H; Nair J
Free Radic Biol Med; 2007 Oct; 43(8):1109-20. PubMed ID: 17854706
[TBL] [Abstract][Full Text] [Related]
20. Use of DNA adducts to identify human health risk from exposure to hazardous environmental pollutants: the increasing role of mass spectrometry in assessing biologically effective doses of genotoxic carcinogens.
Farmer PB; Singh R
Mutat Res; 2008; 659(1-2):68-76. PubMed ID: 18468947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
